NFA
KYNB

Nationwide Fund Advisors’s Kyntra Bio KYNB Stock Holding History

Nationwide Fund Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-9,390
Closed -$12.6M – 729
2017
Q3 		$12.6M Buy
9,390
+798
+9% +$841K 0.05% 519
2017
Q2 		$6.94M Buy
8,592
+5,457
+174% +$3.8M 0.03% 837
2017
Q1 		$1.93M Buy
3,135
+121
+4% +$73.7K 0.01% 1413
2016
Q4 		$1.61M Sell
3,014
-38
-1% -$19K 0.01% 1516
2016
Q3 		$1.58M Buy
3,052
+250
+9% +$118K 0.01% 1514
2016
Q2 		$1.15M Buy
2,802
+116
+4% +$53.1K 0.01% 1641
2016
Q1 		$1.45M Buy
2,686
+622
+30% +$310K 0.01% 1506
2015
Q4 		$1.57M Buy
2,064
+16
+0.8% +$10.6K 0.01% 1476
2015
Q3 		$1.12M Buy
2,048
+809
+65% +$490K 0.01% 1671
2015
Q2 		$728K Buy
1,239
+968
+357% +$563K ﹤0.01% 2037
2015
Q1 		$213K Sell
271
-11
-4% -$8.53K ﹤0.01% 2658
2014
Q4 		$192K Buy
+282
New +$181K ﹤0.01% 2660

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Nationwide Fund Advisors's KYNB Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Kyntra Bio (KYNB) in Q4 2017, closing a stake of 9,390 shares — an estimated $12.6M sold.

Nationwide Fund Advisors first reported a position in KYNB in Q4 2014 and held it in 12 quarters. The position peaked at $12.6M in Q3 2017. 187 funds tracked by Wall St. Rank hold KYNB as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Kyntra Bio position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 9,390 Kyntra Bio shares in Q4 2017, an estimated $12.6M.
  • Nationwide Fund Advisors first reported a position in Kyntra Bio in Q4 2014 and held it in 12 quarters.
  • Nationwide Fund Advisors's Kyntra Bio position peaked at $12.6M in Q3 2017.
  • 187 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.